(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 17.03% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Insulet's revenue in 2025 is $2,071,600,000.On average, 9 Wall Street analysts forecast PODD's revenue for 2025 to be $171,769,047,496, with the lowest PODD revenue forecast at $170,284,256,979, and the highest PODD revenue forecast at $174,652,320,648. On average, 9 Wall Street analysts forecast PODD's revenue for 2026 to be $202,273,511,421, with the lowest PODD revenue forecast at $198,002,500,228, and the highest PODD revenue forecast at $209,091,202,050.
In 2027, PODD is forecast to generate $233,321,384,939 in revenue, with the lowest revenue forecast at $225,110,338,181 and the highest revenue forecast at $242,490,737,112.